tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for Schrodinger Amid Promising Drug Developments and Strategic Growth Potential
PremiumRatingsOptimistic Buy Rating for Schrodinger Amid Promising Drug Developments and Strategic Growth Potential
1M ago
Schrodinger announces initial clinical data from SGR-1505 study
Premium
The Fly
Schrodinger announces initial clinical data from SGR-1505 study
1M ago
Schrodinger appoints Mannix Aklian as chief commercial officer
Premium
The Fly
Schrodinger appoints Mannix Aklian as chief commercial officer
2M ago
Schrödinger, Inc. Reports Strong Q1 Growth Amid Challenges
PremiumCompany AnnouncementsSchrödinger, Inc. Reports Strong Q1 Growth Amid Challenges
2M ago
Schrödinger Reports Strong Q1 2025 Financial Results
Premium
Company Announcements
Schrödinger Reports Strong Q1 2025 Financial Results
2M ago
Strong Performance and Future Potential: Brendan Smith’s Buy Rating on Schrodinger
Premium
Ratings
Strong Performance and Future Potential: Brendan Smith’s Buy Rating on Schrodinger
2M ago
Schrodinger issues statement on FDA phasing out animal testing requirement
PremiumThe FlySchrodinger issues statement on FDA phasing out animal testing requirement
3M ago
Schrödinger’s Strong Software Revenue and Growth Prospects Earn Buy Rating
Premium
Ratings
Schrödinger’s Strong Software Revenue and Growth Prospects Earn Buy Rating
5M ago
Schrödinger, Inc. Reports Mixed Earnings Call Results
Premium
Company Announcements
Schrödinger, Inc. Reports Mixed Earnings Call Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100